TECHNETIUM TC 99M SULFUR COLLOID Drug Patent Profile
✉ Email this page to a colleague
When do Technetium Tc 99m Sulfur Colloid patents expire, and when can generic versions of Technetium Tc 99m Sulfur Colloid launch?
Technetium Tc 99m Sulfur Colloid is a drug marketed by Ge Healthcare and Mallinckrodt and is included in two NDAs.
The generic ingredient in TECHNETIUM TC 99M SULFUR COLLOID is technetium tc-99m sulfur colloid. There is one drug master file entry for this compound. Additional details are available on the technetium tc-99m sulfur colloid profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TECHNETIUM TC 99M SULFUR COLLOID?
- What are the global sales for TECHNETIUM TC 99M SULFUR COLLOID?
- What is Average Wholesale Price for TECHNETIUM TC 99M SULFUR COLLOID?
Summary for TECHNETIUM TC 99M SULFUR COLLOID
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Clinical Trials: | 20 |
| Patent Applications: | 122 |
| DailyMed Link: | TECHNETIUM TC 99M SULFUR COLLOID at DailyMed |
Recent Clinical Trials for TECHNETIUM TC 99M SULFUR COLLOID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ohio State University Comprehensive Cancer Center | PHASE2 |
| National Cancer Institute (NCI) | Early Phase 1 |
| University of Wisconsin, Madison | Early Phase 1 |
US Patents and Regulatory Information for TECHNETIUM TC 99M SULFUR COLLOID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | TECHNETIUM TC 99M SULFUR COLLOID | technetium tc-99m sulfur colloid | SOLUTION;INJECTION, ORAL | 017456-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Mallinckrodt | TECHNETIUM TC 99M SULFUR COLLOID | technetium tc-99m sulfur colloid | SOLUTION;ORAL | 017724-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
